Back

Strategy-specific effects of low-voltage area-targeted ablation added to pulmonary vein isolation: a meta-analysis of randomized controlled trials

13 April 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Workflows in atrial fibrillation ablation Clinical EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Akihiro Sunaga

Kansai Rosai Hospital, Amagasaki (Japan)

6 More presentations in this session

Presentation thumbnail
Feasibility and safety of pulsed-field ablation in atrial fibrillation patients with septal occluder devices: a multicenter case series
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Retrospective evaluation of the prostyle vascular closure device in patients undergoing atrial fibrillation ablation: effects on hemostasis and hospital stay.
Miss I. Bax (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Real-world comparison of spherical pulsed field and point-by-point radiofrequency ablation for pulmonary vein isolation: insights from the best ablate registry
Doctor T. Chiba (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Bilateral left lateral ridge ablation in patients with paroxysmal atrial fibrillation: study rationale and preliminary results
Doctor D. Ciliberti (Casamassima, IT)
Abstract Slides Video
Presentation thumbnail
Unsupervised machine learning of multimodal data to identify atrial fibrillation subgroups likely to benefit from pulmonary vein isolation
Doctor N. Bodagh (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Workflows in atrial fibrillation ablation

The Event

Event poster

EHRA 2026

13 April 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial low-voltage area is associated with poor rhythm outcome and poor efficacy of left atrial additional ablation in patients with long-standing persistent atrial fibrillation ablation
7 April 2024
thumbnail
Congress Presentation
Superior vena cava is associated with improved outcomes in atrial fibrillation ablation, as part of a patient- tailored approach: a systematic review and meta-analysis
13 April 2026
thumbnail
Congress Presentation
Pulmonary vein isolation versus PVI + adjunctive strategy (substrate modification and renal denervation therapy) for the reduction of 12-month AF recurrence
27 August 2023
thumbnail
Congress Presentation
Continuous drag ablation versus point-by-point lesion sets for pulmonary vein isolation: A systematic review and meta-analysis
31 August 2026

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources